| Literature DB >> 26708346 |
Martijn J Wilmer1, Chee Ping Ng2, Henriëtte L Lanz2, Paul Vulto2, Laura Suter-Dick3, Rosalinde Masereeuw4.
Abstract
Improved model systems to predict drug efficacy, interactions, and drug-induced kidney injury (DIKI) are crucially needed in drug development. Organ-on-a-chip technology is a suitable in vitro system because it reproduces the 3D microenvironment. A kidney-on-a-chip can mimic the structural, mechanical, transport, absorptive, and physiological properties of the human kidney. In this review we address the application of state-of-the-art microfluidic culturing techniques, with a focus on culturing kidney proximal tubules, that are promising for the detection of biomarkers that predict drug interactions and DIKI. We also discuss high-throughput screening and the challenges for in vitro to in vivo extrapolation (IVIVE) that will need to be overcome for successful implementation.Entities:
Keywords: drug screening; high-throughput screening; kidney; microfluidics; nephrotoxicity; organ-on-a-chip
Mesh:
Year: 2015 PMID: 26708346 DOI: 10.1016/j.tibtech.2015.11.001
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536